Innovation Pharmaceuticals Concludes Successful Phase 2a Trial of Kevetrin for Ovarian Cancer; Intra-Tumor Modulation of p53 Observed

World News: . []

BEVERLY Mass Feb 08 2018 GLOBE NEWSWIRE -- Innovation Pharmaceuticals Inc (OTCQB:IPIX) the Company a clinical stage biopharmaceutical company, today announces the closure of its Phase 2a clinical trial of Kevetrin for the trea tment o...

More news and information about Innovation Pharmaceuticals, Inc.

Published By:

Globe Newswire: 12:30 GMT Thursday 8th February 2018

Published: .

Search for other references to "innovation" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us